Sound Income Strategies’s Agile Therapeutics AGRX Stock Holding History

Sound Income Strategies’s Portfolio AGRX Stock Details AGRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-1	Closed	-$2.08K	–	1078
2021 Q1	$2.08K	Hold	1	–	–	﹤0.01%	764
2020 Q4	$3K	Hold	1	–	–	﹤0.01%	692
2020 Q3	$3K	Hold	1	–	–	﹤0.01%	638
2020 Q2	$3K	Hold	1	–	–	﹤0.01%	612
2020 Q1	$2K	Hold	1	–	–	﹤0.01%	624
2019 Q4	$3K	Hold	1	–	–	﹤0.01%	548
2019 Q3	$1K	Hold	1	–	–	﹤0.01%	648
2019 Q2	$1K	Hold	1	–	–	﹤0.01%	647
2019 Q1	$2K	Hold	1	–	–	﹤0.01%	576
2018 Q4	$1K	Hold	1	–	–	﹤0.01%	646
2018 Q3	$0	Hold	1	–	–	﹤0.01%	882
2018 Q2	$0	Hold	1	–	–	﹤0.01%	810
2018 Q1	$3K	Buy	+1	New	+$6.61K	﹤0.01%	458

Other funds holding AGRX

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Investor AB Stockholm, Sweden $15.1B AUM 29.02% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

NIM

Needham Investment Management New York $1.96B AUM 101.23% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Sound Income Strategies's AGRX Position: Q2 2021 in Review

Sound Income Strategies sold out of Agile Therapeutics (AGRX) in Q2 2021, closing a stake of 1 share — an estimated $2.08K sold.

Sound Income Strategies first reported a position in AGRX in Q1 2018 and held it in 13 quarters. The position peaked at $3K in Q4 2020. 64 funds tracked by Wall St. Rank hold AGRX as of Q2 2021.

Sound Income Strategies reported no remaining Agile Therapeutics position as of Q2 2021 after selling out during the quarter.
Sound Income Strategies sold 1 Agile Therapeutics share in Q2 2021, an estimated $2.08K.
Sound Income Strategies first reported a position in Agile Therapeutics in Q1 2018 and held it in 13 quarters.
Sound Income Strategies's Agile Therapeutics position peaked at $3K in Q4 2020.
64 funds tracked by Wall St. Rank held Agile Therapeutics as of Q2 2021.

Based on Sound Income Strategies's 13F filing for Q2 2021, filed 13 Jul 2021.